168 related articles for article (PubMed ID: 37279001)
1. Outcomes of Different Quality of Life Assessment Modalities After Breast Cancer Therapy: A Network Meta-analysis.
Kastora SL; Holmquist A; Valachis A; Rocco N; Meattini I; Somaiah N; Peled A; Chatterjee A; Catanuto G; Tasoulis MK; Nava MB; Poortmans P; Pusic A; Masannat Y; Karakatsanis A
JAMA Netw Open; 2023 Jun; 6(6):e2316878. PubMed ID: 37279001
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cosmetic outcome following breast-conserving therapy in trials: panel versus digitalized analysis and the role of PROMs.
Lagendijk M; Vos EL; Nieboer D; Verhoef C; Corten EML; Koppert LB
Breast J; 2018 Jul; 24(4):519-525. PubMed ID: 29316049
[TBL] [Abstract][Full Text] [Related]
4. PROMs following breast-conserving therapy for breast cancer: results from a prospective longitudinal monocentric study.
Kindts I; Laenen A; van den Akker M; Weltens C
Support Care Cancer; 2019 Nov; 27(11):4123-4132. PubMed ID: 30790047
[TBL] [Abstract][Full Text] [Related]
5. Oncoplastic breast-conserving surgery for women with primary breast cancer.
Nanda A; Hu J; Hodgkinson S; Ali S; Rainsbury R; Roy PG
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013658. PubMed ID: 34713449
[TBL] [Abstract][Full Text] [Related]
6. Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis.
Imamura M; Scott NW; Wallace SA; Ogah JA; Ford AA; Dubos YA; Brazzelli M
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013325. PubMed ID: 32734597
[TBL] [Abstract][Full Text] [Related]
7. Aesthetic result after breast-conserving therapy is associated with quality of life several years after treatment. Swedish women evaluated with BCCT.core and BREAST-Q™.
Dahlbäck C; Ullmark JH; Rehn M; Ringberg A; Manjer J
Breast Cancer Res Treat; 2017 Aug; 164(3):679-687. PubMed ID: 28536951
[TBL] [Abstract][Full Text] [Related]
8. Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial.
Merie R; Browne L; Cardoso JS; Cardoso MJ; Chin Y; Clark C; Graham P; Szwajcer A; Hau E
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):819-825. PubMed ID: 28834326
[TBL] [Abstract][Full Text] [Related]
9. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
10. Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults.
Kendrick T; El-Gohary M; Stuart B; Gilbody S; Churchill R; Aiken L; Bhattacharya A; Gimson A; Brütt AL; de Jong K; Moore M
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011119. PubMed ID: 27409972
[TBL] [Abstract][Full Text] [Related]
11. Localization techniques for guided surgical excision of non-palpable breast lesions.
Chan BK; Wiseberg-Firtell JA; Jois RH; Jensen K; Audisio RA
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009206. PubMed ID: 26718728
[TBL] [Abstract][Full Text] [Related]
12. Is immediate imaging important in managing low back pain?
Andersen JC
J Athl Train; 2011; 46(1):99-102. PubMed ID: 21214357
[TBL] [Abstract][Full Text] [Related]
13. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
Bui KT; Willson ML; Goel S; Beith J; Goodwin A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
Cochrane Database Syst Rev; 2013 Jun; (6):CD008933. PubMed ID: 23744561
[TBL] [Abstract][Full Text] [Related]
15. Nipple malposition after bilateral nipple-sparing mastectomy with implant-based reconstruction: Objective postoperative analysis utilizing BCCT.core computer software.
Hart A; Doyle K; Losken A; Carlson GW
Breast J; 2020 Jul; 26(7):1270-1275. PubMed ID: 31925847
[TBL] [Abstract][Full Text] [Related]
16. Reliability of the BCCT.core software in evaluation of breast cosmesis - A systematic review.
Trakis S; Lord H; Graham P; Fernandez R
J Med Imaging Radiat Oncol; 2021 Oct; 65(6):817-825. PubMed ID: 33973358
[TBL] [Abstract][Full Text] [Related]
17. Home-based multidimensional survivorship programmes for breast cancer survivors.
Cheng KKF; Lim YTE; Koh ZM; Tam WWS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy, safety, and acceptability of single-agent poly (ADP-ribose) polymerase (PARP) inhibitors in
Wang J; Zhang Y; Yuan L; Ren L; Zhang Y; Qi X
Aging (Albany NY); 2020 Nov; 13(1):450-459. PubMed ID: 33257598
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of breast cosmetic changes with a computer-software; the breast cancer conservative treatment cosmetic results (BCCT. core) in hypofractionated whole breast irradiation after breast-conserving surgery-supplementary analysis of multicenter single-arm confirmatory trial: JCOG0906.
Nozaki M; Kagami Y; Takahashi M; Machida R; Sekino Y; Shibata T; Ito Y; Nishimura Y; Teshima T; Ushijima H; Nagata Y; Matsumoto Y; Akimoto T; Takahashi K; Murayama S; Uno T; Tsujino K; Hamamoto Y; Nakagawa K; Kodaira T; Hiraoka M;
Breast Cancer; 2022 Nov; 29(6):1042-1049. PubMed ID: 35861936
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
